InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: akhsv777 post# 44905

Wednesday, 06/27/2018 9:27:24 AM

Wednesday, June 27, 2018 9:27:24 AM

Post# of 48316
Point72, Venbio, Nexthera, Millenium, Vanguard......large stakeholders anticipating solid PISCES data this year. Oncosec represents strong value right now with an explosive end-of-year catalyst. Oncosec milestones list still has PISCES interim data slated for 2018. There may have been a misconception by the market that the "trial in progress" poster at ASCO was supposed to be interim data release.....not so.....and shares dropped. Buying opportuniy for LONGS.